- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02746016
Effect of Formula on Infant Behavior
March 28, 2017 updated by: Abbott Nutrition
Effect of Formula Supplemented With Oligosaccharides on Infant Behavior
This is a prospective, multi-center, single-arm study to evaluate the symptoms of formula intolerance in healthy term infants.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
69
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35235
- Alabama Clinical Therapeutics, LLC
-
Dothan, Alabama, United States, 36305
- Southeastern Pediatric Associates
-
-
Arizona
-
Tucson, Arizona, United States, 85712
- Watching Over Mothers and Babies
-
-
Connecticut
-
Norwich, Connecticut, United States, 06360
- Norwich Pediatric Group, PC
-
-
Florida
-
Orlando, Florida, United States, 32825
- Florida Institute for Clinical Research, LLC
-
Saint Petersburg, Florida, United States, 33710
- SCORE Physician Alliance, LLC
-
-
Nebraska
-
Lincoln, Nebraska, United States, 68510
- Women's Clinic of Lincoln, PC
-
-
Ohio
-
Cleveland, Ohio, United States, 44124
- Institute of Clinical Research, LLC
-
Grove City, Ohio, United States, 43123
- Aventiv Research
-
-
South Carolina
-
Charleston, South Carolina, United States, 29414
- Coastal Pediatric Research
-
-
Texas
-
Longview, Texas, United States, 75605
- DCOL Center for Clinical Research
-
San Antonio, Texas, United States, 78229
- Southwest Children's Research Associates, P.A.
-
-
Utah
-
Layton, Utah, United States, 84041
- Tanner Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 week to 1 month (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subject is in good health as determined from subject's medical history by parent report
- Subject is a singleton full-term birth with a gestational age of 37 - 42 weeks
- Subject's birth weight was ≥ 2490 g (~5 lbs. 8 oz.)
- Subject is between 7 and 42 days of age
- Infant was identified by parents as very fussy or extremely fussy in the baseline tolerance evaluation
- Infant is exclusively formula-fed at time of study entry
- Parent(s) confirm their intention not to administer vitamin or mineral supplements, solid foods or juices to their infant from enrollment through the duration of the study
- Subject's parent(s) has voluntarily signed and dated an informed consent form (ICF) prior to any participation in the study
Exclusion Criteria:
- An adverse maternal, fetal or subject medical history that has potential for effects on tolerance, growth, and/or development
- Subject is taking and plans to continue medications, home remedies, herbal preparations or rehydration fluids that might affect gastrointestinal (GI) tolerance
- Subject participates in another study that has not been approved as a concomitant study
- Subject has been fed any formula containing human milk oligosaccharides prior to study enrollment
- Subject has been treated with oral antibiotics within 7 days prior to study enrollment
- Mother intends to use a combination of breast and formula feeding
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Infant Formula supplemented with Oligosaccharides
Ready to feed infant formula ; Feed ad libitum.
|
sole source nutrition
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fussiness
Time Frame: Change from baseline (3 days prior to SD1) to within one day of initiation of study feeding (SD1)
|
Parent Questionnaires
|
Change from baseline (3 days prior to SD1) to within one day of initiation of study feeding (SD1)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fussiness
Time Frame: Baseline to SDAY 29
|
Parent Questionnaires
|
Baseline to SDAY 29
|
Hours of daily crying
Time Frame: Baseline to SDAY 29
|
Parent Questionnaires
|
Baseline to SDAY 29
|
Gastrointestinal Tolerance
Time Frame: Baseline to SDAY 29
|
Parent Questionnaires
|
Baseline to SDAY 29
|
Stool Pattern
Time Frame: Baseline to SDAY 29
|
Parent Questionnaire
|
Baseline to SDAY 29
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2016
Primary Completion (Actual)
October 1, 2016
Study Completion (Actual)
October 1, 2016
Study Registration Dates
First Submitted
April 13, 2016
First Submitted That Met QC Criteria
April 18, 2016
First Posted (Estimate)
April 21, 2016
Study Record Updates
Last Update Posted (Actual)
March 30, 2017
Last Update Submitted That Met QC Criteria
March 28, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- AL19
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrointestinal Tolerance
-
Abbott NutritionCompleted
-
Abbott NutritionCompleted
-
Abbott NutritionActive, not recruiting
-
Cambridge GlycoscienceCompletedGastrointestinal ToleranceIreland
-
Tate & LyleBiofortis Innovation ServicesCompletedGastrointestinal ToleranceUnited States
-
Abbott NutritionCompletedGastrointestinal ToleranceTurkey
-
Comet Bio Inc.Biofortis, Merieux NutriSciencesUnknownGastrointestinal Tolerance
-
Abbott NutritionCompleted
-
Abbott NutritionCompleted
-
Nutricia ResearchCompletedGastrointestinal TolerancePoland
Clinical Trials on Infant Formula supplemented with Oligosaccharides
-
FrieslandCampinaTerminated
-
Abbott NutritionActive, not recruiting
-
Abbott NutritionCompletedGastrointestinal ToleranceUnited States
-
Biostime, Inc.University of California, Davis; University of Illinois at Urbana-Champaign; Children... and other collaboratorsUnknownGrowth | Health | Immune FunctionsChina
-
NestléCompleted
-
Universidad Complutense de MadridHospital General Universitario Gregorio Marañon; Gerencia de Atención Primaria...Completed
-
NestléPuerta de Hierro University Hospital; University of Navarrra Hospital (Clinica... and other collaboratorsCompletedGrowth | Tolerance | Adverse Event | Disorder of Intestine | Disorder LungSpain
-
Société des Produits Nestlé (SPN)Waldkrankenhaus Protestant Hospital, Spandau; Kinderarztpraxis Köllges, Mossakowski... and other collaboratorsCompletedGrowth | Tolerance | Adverse Event | Disorder of Intestine | Formula SatisfactionAustria, Germany, Switzerland
-
Société des Produits Nestlé (SPN)TerminatedInfant DevelopmentUnited Kingdom